Gisela Paulsen
Operationeel Directeur bij Harbinger Health
Vermogen: 50 211 $ op 31-05-2024
Profiel
Gisela Paulsen is currently the Director at Delphi Diagnostics, Inc. and the Chief Operating Officer at Harbinger Health, Inc. He previously worked as the General Manager-Precision Oncology at EXACT Sciences Corp.
from 2020 to 2021 and as the President & Chief Operating Officer at OncoCyte Corp.
in 2022.
Mr. Paulsen received his undergraduate and graduate degrees from the University of Uppsala.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ONCOCYTE CORPORATION
0.14% | 16-12-2022 | 18 325 ( 0.14% ) | 50 211 $ | 31-05-2024 |
Actieve functies van Gisela Paulsen
| Bedrijven | Functie | Begin |
|---|---|---|
Delphi Diagnostics, Inc.
 Delphi Diagnostics, Inc. Medical/Nursing ServicesHealth Services Delphi Diagnostics, Inc. provides healthcare services. The company was founded in 2016 and is headquartered in Austin, TX. | Directeur/Bestuurslid | - |
Harbinger Health
 Harbinger Health Information Technology ServicesTechnology Services Harbinger Health, Inc. is a company based in Cambridge, MA. Harbinger Health is pioneering the detection of early cancer and enabling foundationally new approaches to cancer screening, diagnosis, and management. The company combines advances in artificial intelligence with proprietary insights into the biology of the beginnings of cancer to identify cancer before it is visible or symptomatic with the aim of developing a low-cost, multi-cancer blood test. Harbinger envisions a future where cancer could be kept from forming, making a cancer diagnosis a routine health problem to be addressed rather than a life-altering event to be feared with profound implications for people, healthcare systems, and societies. The company fundamentally transforms cancer care for everyone. The company was founded in 2020 by Alexander Meissner, Sidney Farber, Zachary Smith, Franziska Michor. The CEO is Stephen Hahn. | Operationeel Directeur | 06-09-2023 |
Eerdere bekende functies van Gisela Paulsen
| Bedrijven | Functie | Einde |
|---|---|---|
| ONCOCYTE CORPORATION | President | 16-12-2022 |
| EXACT SCIENCES CORPORATION | Corporate Officer/Principal | 20-04-2021 |
Opleiding van Gisela Paulsen
| University of Uppsala | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| EXACT SCIENCES CORPORATION | Health Technology |
| ONCOCYTE CORPORATION | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Delphi Diagnostics, Inc.
Delphi Diagnostics, Inc. Medical/Nursing ServicesHealth Services Delphi Diagnostics, Inc. provides healthcare services. The company was founded in 2016 and is headquartered in Austin, TX. | Health Services |
Harbinger Health
Harbinger Health Information Technology ServicesTechnology Services Harbinger Health, Inc. is a company based in Cambridge, MA. Harbinger Health is pioneering the detection of early cancer and enabling foundationally new approaches to cancer screening, diagnosis, and management. The company combines advances in artificial intelligence with proprietary insights into the biology of the beginnings of cancer to identify cancer before it is visible or symptomatic with the aim of developing a low-cost, multi-cancer blood test. Harbinger envisions a future where cancer could be kept from forming, making a cancer diagnosis a routine health problem to be addressed rather than a life-altering event to be feared with profound implications for people, healthcare systems, and societies. The company fundamentally transforms cancer care for everyone. The company was founded in 2020 by Alexander Meissner, Sidney Farber, Zachary Smith, Franziska Michor. The CEO is Stephen Hahn. | Technology Services |
